Monday, June 23, 2014

Fwd: CDER New June 23, 2014



---------- Forwarded message ----------
From: U.S. Food & Drug Administration (FDA) <fda@service.govdelivery.com>
Date: Mon, Jun 23, 2014 at 7:33 AM
Subject: CDER New June 23, 2014
To: iammejtm@gmail.com


FDA (U.S. Food and Drug Administration)

What's New on the FDA Drugs Site

June 20, 2014


New and Generic Drug Approvals

June 19, 2014

Drug NameActive Ingredient Dosage Form/RouteSponsor Submission Type
Androderm testosterone Film, Extended Release;Transdermal Watson Labs Labeling Revision
Androgel testosterone Gel, Metered;Transdermal Abbvie Labeling Revision
Androgel testosterone Gel;Transdermal Abbvie Labeling Revision
Androgel testosterone Gel, Metered;Transdermal Abbvie Labeling Revision
Androgel testosterone Gel;Transdermal Abbvie Labeling Revision
Aveed testosterone undecanoate Injectable;Intramuscular Endo Pharms Inc Labeling Revision
Axiron testosterone Solution, Metered;Transdermal Eli Lilly and Co Labeling Revision
Bromfenac Sodium bromfenac sodium Solution/Drops;Ophthalmic Apotex Inc Approval
Combivent Respimat albuterol sulfate; ipratropium bromide Spray, Metered;Inhalation Boehringer Ingelheim Manufacturing Change or Addition
Delatestryl testosterone enanthate Injectable;Injection Endo Pharms Labeling Revision
Delsym dextromethorphan polistirex Suspension, Extended Release;Oral Reckitt Benckiser Labeling Revision
Depacon valproate sodium Injectable;Injection Abbvie Labeling Revision
Depakene valproic acid Capsule;Oral Abbvie Labeling Revision
Depakene valproic acid Syrup;Oral Abbvie Labeling Revision
Depakote divalproex sodium Tablet, Delayed Release;Oral Abbvie Labeling Revision
Depakote divalproex sodium Capsule, Delayed Rel Pellets;Oral Abbvie Labeling Revision
Depakote Er divalproex sodium Tablet, Extended Release;Oral Abbvie Labeling Revision
Fallback Solo levonorgestrel Tablet;Oral Lupin Ltd Approval
Fortesta testosterone Gel, Metered;Transdermal Endo Pharms Labeling Revision
Omnipaque 140 iohexol Injectable;Injection Ge Healthcare Manufacturing Change or Addition
Omnipaque 180 iohexol Solution;Injection, Oral, Rectal Ge Healthcare Manufacturing Change or Addition
Omnipaque 210 iohexol Injectable;Injection Ge Healthcare Manufacturing Change or Addition
Omnipaque 240 iohexol Solution;Injection, Oral, Rectal Ge Healthcare Manufacturing Change or Addition
Omnipaque 300 iohexol Solution;Injection, Oral, Rectal Ge Healthcare Manufacturing Change or Addition
Omnipaque 350 iohexol Solution;Injection, Oral Ge Healthcare Manufacturing Change or Addition
Omnipaque 70 iohexol Solution;Urethral Ge Healthcare Manufacturing Change or Addition
Striant testosterone Tablet, Extended Release;Buccal Auxilium Pharms Llc Labeling Revision
Testim testosterone Gel;Transdermal Auxilium Pharms Labeling Revision
Testosterone testosterone Gel;Transdermal Teva Pharms Labeling Revision
Testosterone testosterone Gel, Metered;Transdermal Perrigo Israel Labeling Revision
Testosterone testosterone Gel;Transdermal Perrigo Israel Labeling Revision
Thalomid thalidomide Capsule;Oral Celgene Labeling Revision

 


FDA Logo

Subscriber Services:
Manage Preferences  |  Unsubscribe  |  Help with this service

Stay Connected:
Visit Us on Facebook Visit Us on Twitter Visit Us on YouTube Sign up for email updates Visit Us on Flickr Visit Our Blog  

This email was sent to iammejtm@gmail.com using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420 Powered by GovDelivery



--
Jeremy Tobias Matthews

No comments:

Post a Comment